CRO experience with First-In-Human (FIH) studies is not universal.
As you’ll see in this case study, Cmed is the exception, applying their in-depth experience and knowledge to build efficient solutions and provide reliable data that was delivered either on or ahead of schedule for a FIH study in patients with solid tumors.
Click here to see the case study: Cmed DA Case Study_How to Ensure Early Statistical Deliveries
